Literature DB >> 23252955

A centralized approach to out-of-province genetic testing leads to cost savings: the Alberta experience.

M Lilley1, S Christian, P Blumenschein, S Chan, M Somerville.   

Abstract

The Genetic Resource Center (GRC) is a centralized process for requesting genetic testing that is not available within the province (Alberta, Canada). In order to assess potential cost savings associated with this process, all applications received by the GRC in 2010 were reviewed, and cost savings were recorded for statistical analysis. Seven areas of cost savings were identified: (i) negotiated pricing, (ii) laboratory selection, (iii) testing setup in-province, (iv) duplicate testing, (v) inappropriate testing, (vi) sequential testing and (vii) testing offered within the province.The total test cost of the 615 applications submitted in 2010 without the GRC process would have been $766,783 (Canadian dollars). A total cost savings of $112,201 was achieved through the GRC, which represents 15% of the total cost of requested testing ($112,201/$766,783). This is the first study to examine areas of cost savings for genetic testing sent out-of-province. The greatest cost savings resulted from the areas of laboratory selection and negotiated pricing. A centralized process to manage out-of-province genetic test requests results in consistency in testing and significant cost savings.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Keywords:  cost savings; funding allocation; genetic testing health care policy

Mesh:

Year:  2013        PMID: 23252955     DOI: 10.1111/cge.12077

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges.

Authors:  Deirdre Weymann; Nick Dragojlovic; Samantha Pollard; Dean A Regier
Journal:  J Community Genet       Date:  2019-07-05

2.  Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system.

Authors:  Sarah E Ali-Khan; E Richard Gold
Journal:  Genet Med       Date:  2017-05-11       Impact factor: 8.822

Review 3.  Availability and funding of clinical genomic sequencing globally.

Authors:  Kathryn A Phillips; Michael P Douglas; Sarah Wordsworth; James Buchanan; Deborah A Marshall
Journal:  BMJ Glob Health       Date:  2021-02

4.  Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey.

Authors:  Philippe D Violette; Suzanne Kamel-Reid; Gail E Graham; M Neil Reaume; Michael A Jewett; Melanie Care; Joan Basiuk; Stephen E Pautler
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.